Assignee
PANDION OPERATIONS INC
US·9 granted patents·13 pending applications·18 citations·filing 2018–2024
Top patents by PatentIndex Score
22 records- 0194US11091527B2IL-2 muteins and uses thereofPANDION OPERATIONS INC·Filed 2019·Granted Aug 17, 2021·5 cites·2 claims
- 0293US11091526B2IL-2 muteins and uses thereofPANDION OPERATIONS INC·Filed 2019·Granted Aug 17, 2021·4 cites·2 claims
- 0391US11466068B2Targeted immunotolerancePANDION OPERATIONS INC·Filed 2020·Granted Oct 11, 2022·2 cites·11 claims
- 0491US10961310B2Targeted immunotolerancePANDION OPERATIONS INC·Filed 2018·Granted Mar 30, 2021·6 cites·7 claims
- 0589US2024239858A1Il-2 muteins and uses thereofPANDION OPERATIONS INC·Filed 2024·Application pending·0 cites
- 0689US2024247039A1Il-2 muteins and uses thereofPANDION OPERATIONS INC·Filed 2024·Application pending·0 cites
- 0780US11965008B2IL-2 muteins and uses thereofPANDION OPERATIONS INC·Filed 2021·Granted Apr 23, 2024·0 cites·19 claims
- 0879US11945852B2IL-2 muteins and uses thereofPANDION OPERATIONS INC·Filed 2021·Granted Apr 2, 2024·0 cites·22 claims
- 0977US11981715B2Tissue targeted immunotolerance with a CD39 effectorPANDION OPERATIONS INC·Filed 2021·Granted May 14, 2024·1 cites·7 claims
- 1070US2025002582A1Targeted immunotolerance with a pd-1 agonistPANDION OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1169USRE50550EIL-2 muteins and uses thereofPANDION OPERATIONS INC·Filed 2022·Granted Aug 26, 2025·0 cites·27 claims
- 1262US2022002409A1Targeted ImmunotolerancePANDION OPERATIONS INC·Filed 2021·Application pending·0 cites
- 1358US2024228619A9Pancreas targeted therapeutics and uses thereofPANDION OPERATIONS INC·Filed 2022·Application pending·0 cites
- 1457US2025320292A1Kidney-glomerular targeted immunotherapyPANDION OPERATIONS INC·Filed 2022·Application pending·0 cites
- 1557US2025019431A1Kidney targeted immunotolerancePANDION OPERATIONS INC·Filed 2021·Application pending·0 cites
- 1652US2024301064A1Pd-1 antibodies, polypeptides and uses thereofPANDION OPERATIONS INC·Filed 2022·Application pending·0 cites
- 1751US2024010722A1Madcam targeted therapeutics and uses thereofPANDION OPERATIONS INC·Filed 2021·Application pending·0 cites
- 1851US2024262905A1Skin targeted immunotolerancePANDION OPERATIONS INC·Filed 2021·Application pending·0 cites
- 1951US2024052034A1Multi-paratopic anti-pd-1 antibodies and uses thereofPANDION OPERATIONS INC·Filed 2021·Application pending·0 cites
- 2049US2022041713A1Targeted immunotolerancePANDION OPERATIONS INC·Filed 2019·Application pending·0 cites
- 2147US2023235004A1Tissue targeted immunotolerance with pd-1 agonists or il-2 muteinsPANDION OPERATIONS INC·Filed 2021·Application pending·0 cites
- 2246US11739146B2MAdCAM targeted immunotolerancePANDION OPERATIONS INC·Filed 2020·Granted Aug 29, 2023·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when PANDION OPERATIONS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →